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Resumo 
 
A migração celular é um fenómeno fundamental e altamente regulado, que 
desempenha um papel activo numa grande variedade de processos biológicos. Por 
exemplo, é essencial para os processos de gastrulação e organogénese durante o 
desenvolvimento embrionário e, também, para o estabelecimento e manutenção da 
homeostasia do organismo durante a vida adulta, onde participa na reparação de feridas e 
na migração de células imunitárias para locais de inflamação. Falhas nos mecanismos de 
migração celular podem originar diversas patologias, tais como inflamações crónicas, 
defeitos congénitos e metastização de tumores. Os processos que permitem a migração 
celular despertam, por isso, grande interesse do ponto de vista terapêutico.  
O mecanismo de migração celular direccionada, também designado por quimiotaxia, 
tem sido principalmente analisado através de estudos em cultura de células imunitárias de 
mamífero. Estes estudos identificaram vários estímulos quimiotácticos, receptores celulares 
e vias de sinalização essenciais para a migração celular. Alguns destes estímulos 
quimiotácticos são compostos por moléculas difusíveis designadas por quimiocinas. Estas 
moléculas são reconhecidas por receptores que se encontram à superfície dos leucócitos, e 
que fazem parte de uma vasta família de receptores celulares, os receptores associados a 
proteínas G ou “G-protein coupled receptors” (GPCRs). Estes promovem respostas por 
parte da célula através de proteínas a eles associadas, as proteínas G ou “G-proteins”. 
Outros tipos de estímulos quimiotácticos, tais como factores de crescimento, tem a 
capacidade de activar outra classe de receptores, os receptores tirosina-cinase ou “receptor 
tyrosine kinases” (RTKs), que são também importantes na promoção de migração celular. A 
activação destes receptores leva ao recrutamento de moléculas sinalizadoras, 
nomeadamente a cinase de fosfatidilinositol (PI3K), importante para o estabelecimento da 
polaridade celular necessária para a migração celular.  
Embora estes estudos em culturas celulares tenham contribuído bastante para o 
nosso conhecimento sobre os mecanismos moleculares da migração celular, pouco se sabe 
acerca da regulação destes mecanismos no contexto de um organismo. É, portanto, 
fundamental o recurso a um modelo animal simples, e ao mesmo tempo relevante, para 
analisar estes processos.  
As células imunitárias ou hemócitos de Drosophila melanogaster (mosca-da-fruta) 
partilham muitas características com os seus equivalentes nos mamíferos, tanto em termos 
de função (fagocitose de microrganismos invasores e de corpos apoptóticos, por exemplo), 
como no seu desenvolvimento hematopoiético (regulado por factores de transcrição das 
famílias GATA, RUNX, e friend-of-GATA). Em semelhança aos leucócitos, os hemócitos são 
expostos a uma elevada variedade de estímulos quimiotácticos que têm de ser integrados 
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para definir a sua direcção de migração. Recentemente, os hemócitos embrionários têm sido 
utilizados como um excelente sistema para o estudo da migração celular e da inflamação in 
vivo. Estes estudos revelaram que os componentes moleculares que regulam a migração 
celular são muito semelhantes aos dos leucócitos. Em D. melanogaster existem receptores 
da familia dos GPCRs e RTKs que desempenham um papel na migração determinados tipos 
celulares. Um exemplo importante, é o receptor Pvr, um RTK, que é necessário à migração 
de hemócitos durante o desenvolvimento embrionário.  
Além disso, a utilização de D. melanogaster como modelo de estudo permite tirar 
partido de tecnologias bastante avançadas e úteis como a microscopia confocal, e de vastas 
bibliotecas de mutantes e transgénicos. Outra vantagem é a utilização do sistema 
GAL4/UAS, que permite determinar a função e localização de diferentes moléculas 
especificamente nos tecidos e células em estudo e no estádio de desenvolvimento 
relevante. 
Assim, o objectivo deste projecto foi analisar o papel da cinase PI3K, dos GPCRs e 
dos RTKs no recrutamento de hemócitos para localizações específicas, durante a terceira 
fase larvar de D. melanogaster. Neste estádio do desenvolvimento, uma parte dos 
hemócitos encontra-se associada a vários tecidos, nomeadamente, à região anterior do 
intestino designada “proventriculus” (PV) e ao epitélio dorsal, onde estas células se 
distribuem por grupos sésseis ao longo do eixo antero-posterior da larva, os “sessile 
patches” (SP).   
Em primeiro lugar, estudou-se a função da cinase PI3K através da expressão nos 
hemócitos de uma forma Dominante Negativa (DN) e de uma forma Constitutivamente 
Activa (CA) desta proteína. Enquanto a primeira bloqueia a acção de PI3K, a segunda 
mantém-la constantemente activada. Quando se expressou a forma DN de PI3K 
especificamente nos hemócitos, observou-se um aumento na população de hemócitos no 
PV, ao passo que nos SP foi observada uma diminuição no número destas células. O efeito 
da forma DN de PI3K na população de hemócitos do PV é semelhante aos resultados 
recentemente obtidos em modelos de ratinho para colite, o que demonstra alguma 
semelhança entre estes dois modelos. Por outro lado, o fenómeno oposto foi detectado após 
a expressão da forma CA de PI3K. Isto é, quando constitutivamente activa, a cinase PI3K 
leva à diminuição do número de hemócitos no PV e ao seu aumento nos SP. Verificou-se 
ainda que as alterações no número de hemócitos são independentes de um potencial efeito 
da cinase PI3K na proliferação e apoptose destas células, confirmado através da utilização 
de imunomarcação com o anticorpo anti-fosfo histona H3 e da técnica de TUNEL. Estes 
resultados revelam que a cinase PI3K poderá ter um papel na regulação da migração de 
hemócitos em ambas regiões da larva mas a diferentes níveis. Para além disso, verificou-se 
que a modulação dos níveis de activação de PI3K leva a alterações na morfologia e 
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propriedades adesivas dos hemócitos, o que indica que PI3K também pode ter um papel na 
regulação das propriedades adesivas destas células. Resumindo, a cinase PI3K parece ser 
necessária para o controlo e manutenção do tamanho destas populações de hemócitos 
possivelmente através da regulação da sua migração e/ou adesão aos tecidos adjacentes.  
Para analisar o papel de receptores envolvidos no recrutamento e na manutenção 
destas populações de hemócitos, preferencialmente a montante da cinase PI3K, efectuou-se 
um rastreio genético baseado na utilização de RNAi para silenciar a expressão de potenciais 
candidatos. Uma vez que existem cerca de 270 GPCRs e 21 RTKs em D. melanogaster, 
optou-se por se estudar apenas RTKs e GPCRs (e suas proteínas G associadas) que se 
sabe serem expressos nos hemócitos. Através deste rastreio genético foi possível identificar 
vários genes com diferentes funções na migração e/ou manutenção das populações de 
hemócitos: GRHR, btl, Pvr, e GRHRII. GRHR é um GPCR que parece ser importante para a 
homeostasia dos hemócitos. Blt é um RTK que poderá ser necessário para a regulação 
negativa do número de hemócitos nos SP. Pvr é também um RTK que poderá desempenhar 
uma função homeostática, mas ao mesmo tempo ser necessário para a migração dos 
hemócitos para o PV e SP, uma vez que se observou uma diminuição no número de 
hemócitos em ambas as localizações quando silenciada a sua expressão. Finalmente, 
identificou-se o gene GRHRII, que poderá funcionar a montante da cinase PI3K, uma vez 
que a expressão de RNAi contra este receptor provocou um efeito semelhante ao observado 
através da expressão da forma DN de PI3K. Dos quatro candidatos identificados, Pvr e 
GHRHII parecem ser os receptores mais relevantes. Sendo estes resultados preliminares, a 
próxima etapa deste projecto será validar os fenótipos observados através de outros 
métodos de análise. Por exemplo, para confirmar a função destes genes pode recorrer-se à 
utilização de mutantes e a análises epistáticas para determinar se o gene GRHRII actua a 
montante da cinase PI3K.  
Em conclusão, estes resultados revelam o papel crucial de diferentes proteínas na 
regulação das populações de hemócitos durante a terceira fase larvar de D. melanogaster. 
Em particular a cinase PI3K, que poderá controlar o número de hemócitos através dois 
processos distintos: i) através da regulação da sua migração, e/ou ii) através da regulação 
das propriedades adesivas da célula. O rastreio genético realizado permitiu ainda identificar 
receptores que poderão estar envolvidos na regulação da migração dos hemócitos destas 
duas regiões, nomeadamente GRHRII e Pvr. De facto, GRHRII poderá funcionar a montante 
da cinase PI3K e ter um papel na regulação dos números de hemócitos do PV e dos SP. 
Estes resultados são especialmente interessantes. Se se confirmar o papel deste GPCR no 
recrutamento de hemócitos, esta será uma descoberta relevante em termos evolutivos, uma 
vez que demonstra, pela primeira vez, que, à semelhança do que ocorre em mamíferos, os 
GPCRs desempenham uma função na migração das células imunitárias em D. 
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melanogaster. Estes resultados também apoiam a ideia de que estas células necessitam de 
integrar diferentes informações provenientes de regiões diferentes para definirem a sua 
direcção de migração. Desta forma, este estudo fornece novos conhecimentos acerca das 
vias de sinalização necessárias durante o recrutamento de hemócitos para regiões 
específicas durante a terceira fase larvar em D. melanogaster e de como estas populações 
são mantidas. Estes conhecimentos poderão representar um importante contributo para o 
estabelecimento dos hemócitos como modelos para o estudo de migração celular.   
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Abstract 
 
Cell migration is an essential and highly regulated mechanism that plays a role in a 
wide variety of biological processes throughout an organism‟s life. The dysregulation of cell 
migration can lead to several pathologies such as chronic inflammatory diseases, congenital 
defects and tumour cell metastasis. Directed cell migration or chemotaxis has been 
intensively analyzed through cell culture studies, mainly utilizing mammalian immune cells. 
These models identified several guidance cues, receptors and signalling pathways important 
for migration of leukocytes to target tissues and to sites of inflammation and damaged 
epithelia. However, a simple but reliable in vivo system is needed to uncover the 
mechanisms underlying immune cell migration within the organism. 
Drosophila melanogaster hemocytes share many important similarities with their 
mammalian counterparts in terms of function and haematopoiesis. Embryonic hemocytes are 
an established model to study cell migration in vivo, due to their amenability to live imaging 
and the array of genetic techniques that allow for functional analysis of molecular processes 
in specific cell types.  
The aim of this project was to analyze the role of Phosphoinositide 3-kinase (PI3K), G 
Protein Coupled Receptors (GPCRs) and Receptor Tyrosine Kinases (RTKs) in hemocyte 
recruitment to specific tissue targets in Drosophila third instar larvae, namely the intestine 
and dorsal epithelium. Here we show that PI3K is important for regulating the size and 
maintenance of these tissue-associated hemocyte populations, possibly by regulating 
hemocyte response to external signals and/or by modifying their adhesive properties possibly 
through Cadherin regulation. In addition, in a candidate screen we identified two receptors, a 
GPCR and an RTK, potentially required for the recruitment and/or maintenance of 
hemocytes at these locations. In the future, these results could help to better understand 
innate immune cell migration and to further establish hemocytes as models for in vivo cell 
migration. 
 
 
 
 
Keywords: Chemotaxis; Cell Migration; Hemocytes; Macrophages; Innate Immunity; 
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Chapter 1. Introduction 
1.1 Cell Migration 
 
Cell migration plays a central role in a wide variety of biological processes [1]. During 
development it is fundamental for several morphogenetic events including gastrulation, the 
formation of the nervous system and organogenesis [2, 3]. During adult life, cell migration is 
essential for normal tissue homeostasis, enabling effective tissue repair, wound healing and 
immune cell migration to sites of infection and inflammation [4]. The failure of cells to 
migrate, or the migration of cells to inappropriate locations can result in congenital defects, 
chronic inflammatory diseases such as rheumatoid arthritis, and cancer metastasis. Thus, 
there is a great interest in understanding cell migration on a molecular level in order to 
develop new therapeutical approaches [1, 5]. There are different modes of cell migration 
depending on the cell type and the context in which it is migrating. Cells can move as single 
entities, groups, or sheet-like layers [3]. Migrating cells must integrate a variety of information 
obtained from their environment, and respond in a spatially and temporally restricted manner 
in order to perform their correct functions.  
Single cell migration has been extensively studied in unicellular model organisms such 
as the social amoeba Dictyostelium amoeba, and mammalian cell culture, where movement 
across two-dimensional substrata is analyzed and the environment can be easily 
manipulated [6-8]. Mammalian immune cells or leukocytes are predominantly used in these 
cell culture studies and have become the archetypal model of single cell migration. In the 
organism, immune cells need to perform a variety of functions that require rapid locomotion. 
One example is the response to injury and infection, where macrophages and neutrophils 
migrate to eliminate invading microorganisms and engulf infected cells and cell debris [9, 10]. 
Migration is also fundamental for homing of naïve T-cells into secondary lymphoid organs for 
immune response initiation and maturation [11]. 
1.2 Chemotaxis 
 
Cell movement is controlled by extracellular guidance cues produced by the 
environment [12]. Directed cell migration, or chemotaxis, is the ability of cells to detect an 
external signal gradient and respond by migrating persistently in one direction, either towards 
the source of the signal, or away from it [8, 13, 14]. Chemotaxis can be thought of as a 
dynamic and cyclical process that begins with the detection of an extracellular signalling cue 
by membrane associated receptors, and leads to cell polarization, where different signalling 
pathways are activated at the cell front (facing the higher concentration of chemoattractant) 
and the cell rear. Subsequent cytoskeletal rearrangements, such as actin polymerization, 
enable the extension of a membrane protrusion or pseudopodium in the direction of 
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movement. Upon adhesion of the pseudopodium to the substrate, the contraction of the cell 
and the release of adhesion connections at the cell rear moves the cell body forward, 
completing the cycle (Fig. 1)  [1, 5, 6, 14, 15]. 
 
 
 
 
 
 
Figure 1 : Schematic representation of cell migration cycle during chemotaxis. Adapted from [14]. 
Currently, two-dimensional studies of single, fast moving cells, particularly leukocytes, 
have offered many valuable insights about the nature of the guidance cues, the receptors 
activated and the signalling pathways required to promote cytoskeleton arrangements inside 
the migrating cell. However, in vivo models are now needed to understand how cells spatially 
and temporally integrate multiple signals to maintain directed cell migration within the 
organism [4]. 
1.2.1 The chemotactic signal - Chemoattractants  
Leukocytes are exposed to a wide variety of chemoattractants that guide their 
migration through tissues. Chemotactic stimuli produced by surrounding cells and tissues 
can be diffusible factors or compounds attached to the extracellular matrix. Chemoattractants 
can include microorganism components, chemicals released by damaged tissues, signalling 
molecules such as complement factors, arachidonic acid metabolites like leukotrienes, 
phosphatidic acid, and importantly, chemokines [12, 16-19]. Chemokines are a family of 
chemotactic cytokines that have emerged as one of the most important regulators of 
leukocyte trafficking. Chemokines are the master controllers of leukocyte migration: they 
trigger leukocyte homing to lymphoid tissues, intravascular leukocyte adhesion and 
transendotelial migration (TEM), and leukocyte migration towards sites of inflammation [17, 
20-22]. An important feature of chemokines is their molecular diversity (there are 
approximately 40 to 50 chemokines in humans), specificity in regulating different leukocyte 
subsets, and their restricted patterns of expression either temporally or spatially in cells and 
tissues. For example, bacterial peptides attract both neutrophils and monocytes with equal 
potency, whereas the chemokine interleukin-8 attracts neutrophils but not monocytes. 
Therefore, a specific combination of chemokines can provide selective leukocyte recruitment 
to a target tissue and thus a specific orientation of the immune response [17, 22, 23].  
1.2.2 The receptors – GPCRs and RTKs 
 Cellular responses to chemoattractants can be mediated by members of the G-
protein-coupled receptor (GPCR) family [21, 23, 24]. GPCRs constitute the largest known 
A D C B Receptor activation 
Cell polarization 
Pseudopodium 
formation 
Attachment  
Stabilization  
Cell contraction 
Rear release 
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superfamily of cell surface receptors and can be found in almost all eukaryotic organisms. 
They control a wide variety of biological processes such as neurotransmission, taste, smell, 
vision, pain, differentiation, growth, immunity, and importantly, chemotaxis [25, 26]. Indeed, 
GPCRs comprise almost 50% of current drug targets. The human genome encodes 
approximately 1000 GPCRs, the majority being „orphan receptors‟ with no identified ligand 
[27]. Human GPCRs have been classified into five families one of which, the Rhodopsin 
family, includes chemokine receptors [26, 27]. GPCRs are composed of seven 
transmembrane α-helices, an intracellular carboxy-terminal tail and an extracellular amino-
terminal segment and mediate their effects through coupling to heterotrimeric guanine 
nucleotide-binding proteins (G-proteins) [25, 28]. G-proteins are composed of one α-subunit 
(Gα), which works as a soluble protein, and a β- and γ-subunits that form the β/γ complex 
(Gβγ). The binding of a chemoattractant promotes a conformational change in the GPCR, 
enabling it to work as a guanine nucleotide exchange factor (GEF) and catalyze the 
replacement of GDP for GTP on the Gα subunit, leading to its release from the Gβγ subunit. 
The free Gα-GTP and Gβγ subunits can positively or negatively regulate downstream 
effectors producing specific biological responses. To prevent chronic activation of the 
receptor, it is negatively regulated by GPCR kinases and β-arrestins [27, 29].  
Other receptors apart from GPCRs can promote chemotaxis, such as the receptor 
tyrosine kinases (RTKs). These receptors are highly conserved across metazoan phyla. The 
human genome encodes approximately 58 RTKs, distributed into 20 subfamilies [18, 30]. 
These receptors have a wide variety of ligands, mostly soluble peptides such as growth 
factors, and regulate cell guidance and other fundamental processes such as cell cycle, 
survival, proliferation and differentiation. RTKs are membrane-spanning, cell surface proteins 
composed of an N-terminal extracellular ligand binding domain and a C-terminal intracellular 
tyrosine kinase domain. In general, RTKs exist as inactive monomers that dimerize upon 
ligand binding. Dimerization induces receptor activation and autophosphorylation of tyrosine 
residues in the intracellular domain, creating many docking sites for proteins containing 
phosphotyrosine-binding domains. This recruits numerous signalling components that 
activate a wide variety of effector cascades. This variety may be required for response 
specificity [31, 32], however, there is also evidence that RTKs may produce a more generic 
signal which can be interpreted differently by cells according to their developmental history 
[33]. The activity of RTKs must be tightly regulated by mechanisms that promote signal 
attenuation and termination, indeed, the dysregulation of approximately 50% of known RTKs 
are associated with human tumours [34, 35].  
1.2.3 The signalling pathways activated - PI3K 
During chemotaxis, receptor activation triggers cell polarization. Here, receptors are 
thought to remain equally distributed on the cell membrane, while downstream signalling 
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molecules start to display strong asymmetrical distributions between the cell leading edge 
and rear (Fig. 2). Studies suggest that localized, asymmetrical activation of 
Phosphatidylinositol 3-kinase (PI3K) is the key event that leads to the definition of the cell 
leading edge [1, 4, 8, 36]. In neutrophils, Dictyostelium, and almost all eukaryotic cell types 
studied PI3K is important not only for defining the leading edge but also for its maintenance, 
and thus efficient cell migration [36]. This accumulation of PI3K at the leading edge is 
stabilized by the activation of its antagonist, the Phosphatase and TENsin homolog (PTEN) 
at the cell sides and rear. PTEN also catalyze the opposite reaction than PI3K, restricting the 
diffusion of PI3K phospholipidic products to the leading edge (Fig. 2) [4, 37].  
PI3K is a member of a conserved family of lipid kinases that generates second 
messengers by phosphorylating membrane lipids, which regulate many intracellular 
signalling pathways that control cell migration, cell adhesion, proliferation and survival, and 
others. PI3Ks are categorized into three classes (I-III) according to their substrate specificity 
and sequence homology. Only class I PI3K is known to be involved in chemotaxis. In 
mammals, class I PI3Ks can be divided in two classes IA and IB. Both classes are 
heterodimers composed of a highly homologous catalytic subunit and a regulatory subunit, 
and use phosphatidylinositol 4, 5-biphosphate (PIP2) as a substrate to generate 
phosphatidylinositol 3, 4, 5-triphosphate (PIP3). Class IA consists of a p110α, β or δ catalytic 
subunit and of a p85 regulatory subunit and is known to be activated by RTKs. Class IB PI3K 
comprises a p110γ catalytic isoform bound to either a p101 or a p84 regulatory subunit and 
is activated by GPCRs [38, 39]. Interestingly, the particular subunit isoforms can be 
specifically used by different immune cells subsets [22, 40] and can be activated in 
temporally distinct events of leukocyte recruitment during inflammation [41]. For example, 
PI3K-dependent homing in T-cells predominantly requires p110γ, whereas B-cells require the 
p110δ isoform [42]. Importantly, the PI3K misregulation can have serious outcome on 
inflammatory conditions. For example, in mouse models of colitis, PI3Kδ mutant mice 
possess macrophages with altered functions that contribute to the pathogenesis of the 
disease [43] and mice bearing a kinase-dead PI3Kγ have an inflammatory intestinal 
phenotype, with increased severity of the colitis [44]. It is clear that PI3K signalling is 
important for regulating chemotaxis, however, many questions remain, including how PI3K 
integrates different incoming signals, and how is the specificity of downstream effectors 
activation achieved to promote cell migration. 
1.2.4 Cytoskeleton reorganization – Rho GTPases 
After the first steps of cell polarization, the accumulation of PIP3 at the leading edge 
results in the recruitment of proteins containing a PIP3-specific pleckstrin homology (PH) 
domain such as GEFs, which in turn have the capacity to activate the Rho GTPase family of 
proteins [4, 38]. 
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Rho GTPases are responsible for regulating the cytoskeleton assembly and 
organization, and are critical proteins in promoting cell migration [12, 15]. Rho, Rac and 
Cdc42 are the most extensively studied members of this family, each controlling signal 
transduction through different pathways with different outcomes. Cdc42 and Rac control 
migration direction by regulating actin polymerization at the leading edge. Cdc42 promotes 
the extension of filopodia (long, thin and needle like protrusions) that serve as a sensor to 
explore the microenvironment, and Rac promotes the formation of lamellipodia (broad, flat 
and sheet like protrusions) that provide the main force to move the cell forward [45, 46]. 
Adhesion to the underlying substratum is 
essential for the stabilization of the 
lamellipodium and is mainly mediated by 
integrins. Rac is also responsible for 
adhesion formation and disassembly at the 
lamellipodium. Simultaneously, the cell 
needs to contract its body and dismantle 
adhesions at the rear to permit the whole 
cell to move. An actomyosin filament 
network (composed of bundles of actin 
filaments associated with myosin II) pulls 
the cell body towards the direction of 
migration and releases rear adhesions; both 
processes are dependent on Rho activity 
(Fig. 2) [5, 45]. The maintenance of cell 
polarity is achieved by positive feedback 
between PI3K signalling and Rho GTPases 
[8, 38]. Thus, Rho GTPases coordinately 
regulate several essential steps during 
chemotaxis through their effect on the 
various components of the cytoskeleton.  
1.3 Drosophila hemocytes as a model to study single cell migration 
 
Drosophila melanogaster (or fruitfly) is an excellent model system to study biological 
processes in vivo, due to its short lifecycle, sophisticated genetic tools available, fully 
sequenced genome, and its high level of conservation of genetics, cell biology and even 
complex processes with vertebrates. D. melanogaster has successfully served as a model 
for a variety of biological questions and opened the way to innumerable studies on 
mammals. For example, it is widely used to study the molecular pathways that regulate 
innate immunity [47] and cell migration, using advanced microscopy techniques [48, 49]. 
Figure 2: Scheme of the spacial localization of key 
components implicated in chemotaxis. Gradient of 
activation of PI3K (green) and PTEN (red) is shown. 
Adapted from [8]. 
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Unlike the mammalian immune response that has innate and adaptive components, D. 
melanogaster immune response is only composed of the innate part, comprising a humoral 
(mainly induced by the fat body, a functional equivalent of the mammalian liver) and a 
cellular system (composed of immune circulating cells called hemocytes) [50, 51]. Similarly 
to mammalian leukocytes, hemocytes can perform phagocytosis and encapsulation of 
pathogens, release of antimicrobial peptides (AMPs) and reactive oxygen species (ROS), 
clearance of apoptotic cells, deposition of extracellular matrix (ECM), and migration to sites 
of damaged tissues [52-54]. Hemocytes can be divided in three subtypes according to their 
structure and function. Plasmatocytes are the equivalent of the mammalian macrophages 
and represent 95% of all mature hemocytes, phagocytosing dead cells and pathogens and 
producing AMPs and ECM. Crystal cells that constitute the remaining 5% of mature 
hemocytes are non-phagocytic cells with crystal inclusions that mediate melanization at 
wounds, generating cytotoxic free radicals to kill pathogens. Last, lamellocytes are large, flat 
cells, involved in the encapsulation and neutralization of objects too large to be 
phagocytosed, such as parasitoid wasp eggs. They are not usually observed in healthy flies 
and arise only after wasp infestation [51, 52]. 
  Haematopoiesis occurs in two waves during D. melanogaster development: the first 
wave gives rise to embryonic hemocytes (EH) and occurs in the head mesoderm of early 
embryos; the second wave takes place in the larval haematopoietic organ called the lymph 
gland, giving rise to lymph gland-derived hemocytes (LGH). Under normal conditions, LGH 
do not enter in circulation until the onset of metamorphosis, at which point the lymph gland 
disintegrates and releases mature hemocytes into circulation. Pupal and adult hemocyte 
populations are composed of a mixture of embryonic and lymph gland-derived hemocytes 
[55, 56]. Strikingly, D. melanogaster haematopoiesis presents many parallels with vertebrate 
blood cell development: both occur in two waves and share many components of the 
signalling pathways that regulate this process, including transcription factors from the GATA, 
RUNX, and friend-of-GATA families [50, 56]. 
During embryogenesis, hemocytes migrate and populate the entire embryo where 
they perform a variety of tasks important not only for the immune defences, but also for 
tissue remodelling (e.g. production of ECM and removal of cell debris) [52]. Similar to 
mammalian leukocytes, hemocytes are exposed to multiple chemotactic signals that must be 
integrated to define their direction of movement. Studies in the embryo suggest that 
hemocytes use distinct mechanisms to migrate during development and to undergo 
chemotaxis towards several targets such as apoptotic bodies, pathogens and damaged 
tissues. The hemocytes first disperse from the head mesoderm by migrating through the 
embryo along invariant and developmentally programmed pathways. This process is 
promoted by the Platelet derived growth factor/Vascular endothelial growth factor Receptor 
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(Pvr) and by the coordinated expression of two of its ligands, Pvf-2 and -3 [57, 58]. However, 
hemocytes can also leave these programmed pathways and be attracted to embryonic 
wounds by H2O2, undergoing a Pvr-independent, but PI3K-dependent chemotaxis [57, 59]. 
Importantly, studies demonstrate that the Rho GTPase family is essential for hemocyte 
migration and recruitment to wounds in the embryo [60, 61]. Two other actin regulators 
known to be important for hemocyte polarization during embryogenesis are Fascin and Ena, 
both of which have also been correlated with invasiveness of cancer cells in other systems 
[62, 63]. 
In the third instar larva, approximately two-thirds of the hemocytes circulate in the 
hemolymph ("blood"), but hemocytes are also found interacting with tissues [64]. Indeed, 
approximately one third of hemocytes attach to the dorsal epithelium, forming the so-called 
sessile patches (SP), patterned clusters of hemocytes along the longitudinal axis of the larva 
(Fig. 3) [65]. In addition, a small population of hemocytes has recently been reported to 
associate with the gut, at the proventriculus (PV) that forms the junction between the foregut 
and the midgut (Fig. 3) [66]. Several genetic screens have been performed in the larva 
offering further insights into possible regulators of hemocyte development and homeostasis. 
These have provided interesting phenotypes pointing to good candidates for further analysis 
in the context of cell migration [64, 67-69].  
However, the majority of what is known about hemocyte migration comes from 
studies in embryos. Consequently a lot of questions remain about larval, pupal or adult 
hemocyte chemotaxis, some of which specific to these contexts. For instance, how are 
embryonic hemocytes partitioned into different tissue-associated hemocyte populations in the 
larvae, such as the SP and the PV-enclosed hemocytes? What kind of chemotactic signals, 
receptors, and signalling pathways are used by hemocytes to undergo chemotaxis and 
populate these two specific locations and what maintains them, after chemotaxis, associated 
with these tissues?  
Given the conservation between hemocytes and leukocytes in contexts such as 
haematopoiesis and innate immunity, the types of receptors and signalling pathways 
essential for leukocyte migration could also be important for hemocyte "homing" and 
inflammation in the larvae. The fly genome codes for approximately 200 to 270 GPCRs, 
including olfactory and gustatory receptors [26, 70]. Phylogenetic analyses of human and D. 
melanogaster GPCRs indicates high level of evolutionary conservation of GPCR sequences. 
However, some groups of GPCRs present in humans, such as immune-related chemokine 
receptors have not been identified in D. melanogaster, suggesting a relatively recent 
evolutionary origin [25]. Interestingly, one GPCR, Trapped in endoderm 1 (Tre1), is known to 
be important for cell migration in Drosophila embryos. The mutation of this specific gene 
affects a specific step of germ cell migration: their transendothelial migration from the midgut 
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to the mesoderm. [71, 72]. RTKs also play an important role in mediating cell migration in 
several biological processes in D. melanogaster, which genome codes for approximately 21 
RTKs, much fewer than vertebrates [73]. The fly epidermal growth factor receptor (Egfr), for 
instance, has an important role in guiding border cell migration during oogenesis [74, 75]. 
Breathless (btl), a D. melanogaster fibroblast growth factor receptor is essential for 
controlling cell migration during tracheal development [76]. Importantly for this study, the 
RTK Pvr is expressed in embryonic hemocytes [77] and promotes their migration, as 
discussed previously [57], but also their proliferation [78] and survival [79]. 
 D. melanogaster hemocytes carry out many important functions throughout the fly life 
cycle. They perform all these tasks in the continuously changing environment of a complex 
multicellular organism full of competing chemotactic signals. Given the striking similarities 
between hemocytes and their mammalian counterparts in terms of function, haematopoiesis 
and some basic molecular mechanisms of migration, D. melanogaster hemocytes have the 
potential to be powerful models to study cell migration in the context of a living organism.  
1.4 Main goals 
Recently in the laboratory, PI3K has been found to regulate homeostasis of the gut-
associated hemocyte population in the larva. Building on these recent data, the goals of the 
project were the following. 
i) To further analyze the role of PI3K in regulating two larval tissue-associated hemocyte 
populations, the PV and SP.  
ii) To identify potential receptors working upstream of PI3K in hemocyte migration to these 
two locations, by performing a candidate genetic screen on the GPCRs and RTKs expressed 
in hemocytes. We aimed to systematically address the role of GPCRs, RTKs and PI3K in 
hemocyte guidance to the PV and SP. 
iii) To decipher some of the potential effectors mediating PI3K-dependent regulation of 
hemocyte localization. 
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Chapter 2. Experimental procedures 
2.1 Drosophila stocks and husbandry  
Drosophila stocks (supp. Table 1) were obtained from Bloomington Stock Center and 
Vienna Drosophila RNAi center (VDRC), except Tre1∆EP5, kindly provided by R. Lehmann.  
To analyze the function of different molecules specifically in hemocytes we took 
advantage of an important technique in Drosophila genetics, the GAL4/UAS system [80]. 
This system utilizes two components from yeast: the GAL4 transcription factor, placed under 
the control of a tissue specific promoter of choice; and the UAS (upstream activating 
sequence) regulatory sequence placed upstream of a desired sequence: a gene of interest 
for misexpression, a modified (for example dominant negative or constitutively active) form of 
a gene, or RNAi against a specific gene. When GAL4 is expressed, it binds to the UAS 
sequence, activating transcription of the desired sequence in a tissue-specific manner. It is 
also very useful to drive the expression of a fluorophore (e.g. the Green Fluorescent Protein, 
GFP) in a specific group of cells, in order to visualize them through microscopy.  
All analyses were performed using HmlΔ-GAL4, UAS-GFP (or HmlΔ-GAL4, UAS-
nlsCherry for the TUNEL assay) recombinant flies. In these recombinants the GAL4 gene is 
placed under the control of a hemocyte gene promoter, Hemolectin (Hml) [81], thus driving 
the expression of GFP or Cherry (tagged with a nuclear sequence) respectively in the 
hemocyte cytoplasm or nucleus. The Hml promoter was chosen, because it is known to be 
expressed in approximately 95% of total hemocytes [69], but not in prohemocytes or 
lamellocytes. These flies were crossed to lines carrying modifiers of gene expression (such 
as RNAi or dominant negative genes) under the control of UAS, as described below.  
Our study also relied heavily on the powerful RNAi technique, which is an excellent tool 
to study gene function by effectively silencing expression. The RNAi construct consists of an 
inverted repeat sequence corresponding to approximately 500 bp of the target gene that is 
placed under the control of an UAS. The transcription of this construct leads to the formation 
of a double-stranded RNA (dsRNA) that is cleaved in short fragments of approximately 20bp 
by the enzyme Dicer. These short dsRNAi fragments interact with the RNA-induced silencing 
complex (RISC), and specifically promote the cleavage of the targeted mRNA. RNAi is 
dominant; however, it usually does not result in the complete abolishment of gene 
expression, and can give rise to a hypomorphic phenotype.  
Combining the GAL4/UAS system and RNAi techniques, we can express RNAi or other 
constructs against a target gene in a specific tissue or cell type, such as hemocytes, and 
address the function of a gene in these particular cells.  
For PI3K and Rac1 phenotype analyses, we used Constitutively Active (CA) and 
Dominant Negative (DN) forms of these proteins, expressed under the control of an UAS 
sequence (suppl. Table 1). Both types of constructs have a dominant effect on the function of 
10 
the endogenous protein, competing with it for target binding and activating or suppressing 
signalling, respectively. In the case of PI3K, two different CA constructs were analyzed, 
which in addition to having two different insertion sites, differ in that one has a myc tag (CA-
myc) which leads the active protein directly to the cytoplasmic membrane [82]. 
For the genetic screen we used UAS-RNAi constructs from the Harvard (TRiP RNAi) or 
VRDC collections (supp. Table 1). 
The PI3K and Rac1 analysis and the RNAi screen were performed on the F1 progeny 
of HmlΔ-GAL4, UAS-GFP (or HmlΔ-GAL4, UAS-nlsCherry, for TUNEL analysis) crossed with 
lines containing the constructs of interest (CA, DN, or RNAi). As the lines we used 
correspond to different backgrounds, we had to adapt our controls to each of them. 
Therefore our controls were F1 progeny of HmlΔ -GAL4, UAS-GFP (or HmlΔ-GAL4, UAS-
nlsCherry) crossed with a line of the corresponding background: y1 w1118 for the PI3K and 
Rac1 phenotype analysis, y1v1 for the TRiP RNAi, w1118 for the Tre1 mutant, and y w1118; P 
{attP,y[+],w[3`]} for the VDRC RNAi, a line that has an empty vector inserted in the same site 
as the RNAi constructs (controlling for the effect of the construct insertion itself). 
 Fly crosses were performed at 25ºC and flipped to new vials every two days. The 
progeny was raised at the 29ºC to increase the efficiency of the GAL4/UAS system.  
2.2 Genetic screen 
We chose to analyze two distinct tissue-associated hemocyte populations and see 
whether hemocytes expressing the RNAi had a defect in migrating to these locations. The 
populations were the proventriculus (PV) -enclosed hemocytes and the sessile patches (SP). 
The larva possesses between 6 to 7 SP at the stage we analyzed; we decided to always 
image the same two central SP, hereafter referred to as anterior and posterior (Fig. 3). The 
guts of at least 7 female L3 wandering larvae (L3W) per phenotype were dissected and the 
PV region was imaged for hemocyte quantification. Prepupa males from progeny, usually 5 
per genotype, were mounted and SP were imaged for hemocyte quantification. Both 
hemocyte quantifications were compared to the appropriate control to identify defects in cell 
migration. Besides quantifying hemocytes we also looked for alterations in their morphology 
and behaviour in these different genetic contexts. For the Tre1∆EP5, only males were 
analyzed: as this gene is on the X chromosome, when crossing males Tre1∆EP5 with HmlΔ-
GAL4, UAS-GFP females, only the F1 male progeny retain the mutant allele.  
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2.3 Dissection  
Guts from L3W larvae were dissected in ice-cold Phosphate Buffered Saline (PBS), on 
ice, then mounted in ice-cold mounting medium (Glycerol + 1 x PBS (1:4) + 2% DABCO (1,4-
diazabicyclo[2.2.2]octane)) on a slide, with one-coverslip-high bridge, and immediately 
imaged, except when immunostained. 
2.4 Bleeds 
Circulating hemocytes were retrieved from L3W larvae by bleeding four larvae, of the 
same gender, into 20L of PBS, where hemolymph was left to settle for 20 minutes. They 
were then imaged immediately or fixed for 15 minutes in 4% formaldehyde in PBS and 
mounted in mounting medium. For cell morphology analysis, we bled control and PI3K CA or 
DN lines into the same drop of PBS (with control hemocytes expressing one fluorophore and 
PI3K CA or DN another, using UAS-GFP or UAS-nlsCherry) in order to have an internal 
control. To control for the effect of different fluorophores on cell morphology, colours were 
switched upon repetition. All scoring was performed blind on colour-free images. 
2.5 Prepupa mounting  
To image the SP, male larvae at the onset of pupariation, which had just stopped 
crawling, were selected. Prepupae were mounted in a slide with double sided tape with a 
five-coverslip-high bridge and a drop of Halocarbon oil 700 and immediately imaged. 
Figure 3: Schematic representation of the genetic screen assay using an example of downregulation of gene X 
by RNAi. 
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2.6 Immunochemistry 
The following antibodies were used: rabbit anti-PH3 (Phospho-histone H3, 1:500; 
Sigma), rat anti-DE-Cadherin (1:100; Developmental Studies Hybridoma Bank), rabbit anti-
GFP (1:2000; Invitrogen), mouse anti-GFP (1:1000; Roche). Secondary goat anti-mouse 
Alexa568, goat anti-rabbit Alexa488, goat anti-rabbit Alexa568 and goat anti-mouse 
Alexa488 were all used at 1:200 (Invitrogen). Immunolabelling was performed as follows: 
dissected guts and bleeds, from the same gender, were fixed for 15 minutes in 4% 
formaldehyde in 1x PBS and then washed in PBST (0.1% Triton X-100 in PBS1x; Sigma-
Aldrich). Guts were serially dehydrated in methanol and left in 100% methanol for 1 hour at -
20˚C. Guts were rehydrated by following the reverse procedure and washed in PBST. Guts 
and bleeds were incubated 1 hour at room temperature (RT) in blocking solution (PBST + 1% 
Bovine Serum Albumin), before an overnight incubation at 4˚C with primary antibodies 
diluted in blocking solution. Samples were rinsed and washed 6x 25 minutes in PBST, 
incubated 30 minutes in blocking solution, then 1.5 hour in secondary antibodies at RT. After 
3x 10 minutes washing (PBST), the samples were incubated in DAPI solution (4', 6-
diamidino-2-phenylindole; 1µm/ml, 5 minutes at RT) and washed 3x 10 minutes before 
mounting. 
For TUNEL (Terminal deoxynucleotidyl transferase dUTP nick end labelling) analysis, 
guts and bleeds were fixed and washed as described above, before permeabilisation for 20 
minutes on ice (0.1% sodium citrate 0.1% Triton X-100 in PBS). A positive control was 
incubated at 37˚C for 30 minutes in a solution of 2.5% DNAse1 in 10x buffer (50 mM Tris-
HCl, pH7.5, 1 mg/mL BSA), in a humidity chamber. The TUNEL reaction was carried out 
using the kit as recommended by the manufacturer (Roche, In Situ Cell Death Kit, AP), with 
90 minutes or 1 hour incubation at 37˚C for guts and bleeds respectively. The samples were 
washed in PBS before DAPI staining, as described above. Remaining Cherry fluorescence 
was sufficient to visualize hemocytes in these experiments. 
All immunolabelling experiments were repeated at least three times, with three or 
more guts per condition in each experiment. For bleed samples (TUNEL, PH3-staining), we 
aimed for 1000 free-hemocytes imaged per condition in each experiment. 
Phalloidin staining was performed on hemocyte bleeds. The bleeds were fixed as usual 
and incubated 30 minutes at RT in a blocking solution (PBST + 1% Bovine Serum Albumin). 
The bleeds were incubated with phalloidin (1:200) and DAPI (1 µm/ml) for 30 minutes. Then 
washed 1 hour in PBS and mounted in mounting medium. 
2.7 Cell clustering assay 
Hml∆Gal4>UAS-GFP, PI3K CA larvae, Hml∆Gal4>UAS-GFP, PI3K DN larvae or 
control Hml∆Gal4>UAS-GFP larvae were bled into 40 µl of Schneider medium with or without 
30 mM EGTA. The cells were submitted to a gentle agitation for 20 min, and then left to 
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settle for 20 min before fixation and imaging. Fluorescence from the GFP remained sufficient 
after fixation to visualize the hemocytes. 
2.8 Imaging 
Imaging was performed using a confocal laser line-scanning microscope (LSM 5 Live; 
Carl Zeiss), a confocal point-scanning microscope (LSM710; Carl Zeiss), using a 40x oil 
objective (except for the clustering analysis, 10x air), or a Widefield Fluorescence 
Microscope (DM5000B; Leica Microsystems; 5x, 10x, 20x and 40x air objectives). Images 
were analyzed using Fiji (ImageJ NIH) and produced using Adobe Photoshop and Illustrator. 
2.9 Scoring and statistical analysis 
Gut and sessile hemocytes were scored manually from original images on Fiji software.  
For cell morphology analysis, we categorized cells in three morphological groups: 
round, with few or no lamellae; intermediate, with some filopodia and partial lamellae; and 
serrate, with a large, well spread and serrated lamella around the cell periphery. We blind 
scored each category from colour-free images, assigning genotype after scoring.  
For hemocyte-clustering assay, area measurements were done automatically with Fiji 
software. The areas were grouped in categories according to the corresponding hemocyte 
number, this correspondence was based on area measurements performed manually on 
single and grouped hemocytes, where, for example, a single cell can have an area between 
20 and 90 µm2 (mean of 60 µm2). The categories chosen were:  20-90 µm2 (one cell); 90-150 
µm2 (clusters of two cells); 150-600 µm2 (clusters of three to ten cells); 600-3000 µm2 
(clusters of eleven to fifty cells); 3000-15000 µm2 (clusters of fifty-one to two hundred cells). 
This assay was performed three times giving consistently the same profile. 
For all analyses, we compared only guts, SP or bleeds from the same gender, because 
previous analysis pointed out that hemocyte numbers differ between genders. Statistical 
significance was defined by pair-wise comparison to controls using the Mann-Whitney U test. 
Indicated p-values are two-tailed. Calculations and graphs were produced using Excel 
(Microsoft) and Prism (Graphpad). 
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Chapter 3. Results 
3.1 PI3K phenotype characterization 
PI3K is known to be important for directional migration of single motile cells in a variety 
of organisms, including homing of immune cells [11, 42] in mammals, and hemocyte 
recruitment to wounds in Drosophila embryos [57]. For this reason, we decided to analyze 
whether PI3K could have a role in homing of tissue-associated hemocytes. 
3.1.1 A balance in PI3K signalling is required for regulation of tissue-associated 
hemocytes 
To investigate whether the localization of tissue-associated hemocytes is regulated by 
the PI3K signalling pathway, we analyzed the behaviour and number of two hemocyte 
populations: PV-enclosed hemocytes and SP, with either inactivated (DN) or constitutively-
activated (CA) PI3K signalling. We manipulated Dp110 (PI3K92E), the only catalytic subunit 
of Class I PI3K in D. melanogaster [83]. In comparison to control larvae (Fig. 4I, B, F), we 
observed significantly more hemocytes at the PV (Fig. 4I, C) and less in both SP (Fig. 4J, G) 
when a PI3K DN transgene was specifically expressed in hemocytes. Conversely, 
significantly less PV hemocytes where found when expressing a myc-tagged PI3K CA 
construct (CA-myc; Fig. 4I, D) and a high number of hemocytes were observed in the sessile 
population (Fig. 4J, H). In addition, when we tested a second CA construct with a different 
insertion site (CA), we also observed fewer hemocytes in the PV than in the control (Fig. 4I) 
and more in both sessile patches (Fig. 4J). However, the myc-tagged PI3K CA construct had 
a stronger effect then the non-tagged PI3K CA construct suggesting that the myc-tag, by 
recruiting the PI3K CA protein to the cytoplasmic membrane, makes it even more efficient.  
These data suggest that active PI3K signalling in hemocytes is required for regulating 
the size of these tissue associated hemocytes. PI3K signaling in hemocytes is not required 
for the initial recruitment to the PV, this may rely on another signal, but appears to be 
necessary for recruitment to the SP  
3.1.2 Changes in population size are not explained by alterations in cell survival or 
proliferation  
PI3K regulates many cellular processes including proliferation and survival [84]. 
Therefore, we tested whether alterations in hemocyte survival or proliferation rates could 
account for the changes in the number of PV hemocytes or in the sessile population in larvae 
with modified PI3K signalling. Proliferation was analyzed by an anti-phosphohistone H3 
(PH3) immunostaining that labels mitotic nuclei specifically at the point of the cell cycle when 
Histone H3 is phosphorylated. We also analyzed apoptosis using the TUNEL technique, 
which labels apoptotic cells by detecting DNA fragmentation through an enzymatic reaction. 
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These analyses were performed on PV-enclosed hemocytes and in bleeds, but we couldn‟t 
perform them in the SP due to technical limitations; however, circulating hemocytes 
 
 
 
retrieved from bleeds should behave similarly to the sessile population since SP are derived 
from the circulation. Both percentages of apoptosis and proliferation were very low in normal 
conditions, as previously reported [85, 86], and were not significantly affected in Hml>PI3K 
CAmyc and Hml>PI3K DN larvae PV-enclosed hemocytes or in the circulating population 
(Table 1). Although we did not find PH3-positive hemocytes within the PV in any of the 
genetic backgrounds analyzed (Table 1), we consistently observed dividing cells among the 
neighbouring gut cells in the PV, in particular within a known stem cell niche [87] (Suppl. Fig. 
1D-F).  
 
 
 
Figure 4: Fine-tuned regulation of PI3K signaling regulates hemocyte number at the PV and at SP. A: 
Schematic of upper midgut showing location of PV-enclosed hemocytes (green). B-D, F-H: Representative 
examples of PV and SP hemocytes from control Hml∆>GFP larva (B,F); Hml∆>GFP, PI3K DN larva (C,G); 
Hml∆>GFP, PI3K CAmyc larva (D,H). E: Scheme of a prepupa. I: Statistical analysis of PV-hemocyte number 
reveals a lower number in PI3K CA larvae and a higher number in PI3K DN larvae when compared to the control. 
J: quantification of the number of hemocytes present in the posterior SP reveals a lower number in PI3K CA 
prepupa and a higher number in PI3K DN prepupa when compared to the control. Dashed boxes in A and E 
correspond to the regions imaged in the next panels. Bars in I and J represent means and standard error of the 
mean. Scale bars: 20 µm. *: p<0.05; **: p<0.01; ***: p<0.001. 
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Table 1: PI3K signalling does not affect cell death or proliferation of hemocytes in L3W larvae. 
Quantifications of the percentage of cell proliferation and apoptosis upon modulating PI3K activity. Percentages 
are displayed as the mean of three independent experiments, except when indicated. (*): this experiment was 
only performed twice but yielded similar results; sd: standard deviation 
 
PV - hemocytes Circulating hemocytes 
 
Control PI3K DN PI3K Camyc Control PI3K DN PI3K Camyc 
Proliferation 
(%) 
0     
sd:0 
0        
sd:0 
0        
sd:0 
0,6  
sd:0,14 
0,6 
sd:0,26 
0,5 
sd:0,31 
Apoptosis 
(%) 
0     
sd:0 
2,09 
sd:1,93 
0,71   
sd:1,08 
0,14* 0,24* 0,1* 
 
3.1.3 Alteration in population size may be partially explained by differences in the 
adhesive properties of the cells  
During our quantification of PV-hemocytes, we noticed a difference in appearance 
and size of hemocytes in the different PI3K contexts (Fig. 4C, D). Hml>PI3K DN hemocytes 
were smaller and rounder than controls while Hml>PI3K CAmyc hemocytes were more 
spread (Fig. 4B-D). One hypothesis is that this reflects the space available in the PV for the 
cells to spread in each condition, due to the respective lack or excess of hemocytes. 
However, when we imaged live cells from circulation ex vivo, which are free of space 
constraints, we noticed a similar effect of PI3K modulation on cell morphology. We observed 
different cell morphologies in control bleeds, which is in agreement with the literature [88, 
89]. These different morphologies were categorized in three groups: round, with few or no 
projections; intermediate, with some filopodia and partial lamellae; and serrate, with large, 
well-spread and serrated lamellae (Fig. 5). Interestingly, when compared to controls, the 
Hml>PI3K DN hemocyte population had a slightly greater proportion of round cells whereas 
the Hml>PI3K CAmyc population had a significantly greater proportion of serrate cells (Fig. 
5). Therefore, the change in cell morphology observed in the PV in different PI3K contexts 
correlates with a change in the global hemocyte population, suggesting a modification of the 
adhesive properties of the cells to the substrate.  
 
 
 
Figure 5: Cell morphology distribution in live bleeds is altered by PI3K signalling. Representative images of 
cell morphology categories observed in live bleeds, and graph showing the distribution of these classes in 
Hml∆>GFP, Hml∆>GFP, PI3K CAmyc (CA) and Hml∆>GFP, PI3K DN (DN) larvae, as compared to the control. 
White dashed line added to better illustrate cell edges. *: p<0.05; **: p<0.01. Bar scales: 25 µm 
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We also noticed, in our ex vivo preparations, that circulating hemocytes from 
Hml>PI3K CAmyc larvae tended to form groups more often than control or Hml>PI3K DN 
hemocytes, further suggesting a change in cell-cell adhesion in cells with over-activated 
PI3K. To quantify this phenotype, we performed a hemocyte-grouping assay by which we 
examined the number and size of cell groups in each context, using an automated analysis 
of fluorescence area. In control larval bleeds (Hml∆>GFP), hemocytes appeared mostly, as 
single circulating cells; small groups of cells are relatively common (aprox. 25% of the 
population) and bigger groups with more than 10 cells are rare (Fig. 6A, D). The Hml>PI3K 
DN circulating population had a higher percentage of single hemocytes and very few 
hemocyte clusters of any size when compared to the control (Fig. 6B, D). In contrast, the 
Hml>PI3K CAmyc hemocyte population had a lower percentage of single circulating cells 
and a higher percentage of small and big groups (Fig. 6C, D) when compared to the control. 
This suggests that PI3K signalling modifies cell-cell adhesive properties of the hemocytes. 
  
 
 
Altogether, these results reveal the importance of finely-tuned regulation of PI3K 
signalling for the proper maintenance of hemocytes at the gut and SP, and demonstrate that 
these changes observed upon modulation of this pathway could be explained in part by a 
role for PI3K in cell adhesion (see Discussion). 
Figure 6: PI3K signalling modulates the formation of cell-to-cell adhesion between hemocytes. A-C: 
Representative images of hemolymph smears from control and PI3K-modulated hemocytes (10x). A: 
Hml∆>GFP. B: Hml∆>GFP, PI3K DN (DN). C: Hml∆>GFP, PI3K CAmyc (CA). Scale bar represents 100 µm. D: 
Graph showing the distribution of cluster size (µm
2
) in PI3K-modulated hemocyte smears. 
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3.2 Upstream of PI3K: Genetic screen for receptors required for hemocyte location 
After characterizing the phenotype obtained upon modulation of PI3K signalling, we 
aimed to find receptors that could act upstream of PI3K in hemocyte navigation. We decided 
to performed an RNAi candidate screen on a selective list of RTKs and GPCRs and their 
associated G-proteins, to identify those that show defects in cell migration; particularly 
interesting would be those giving a similar phenotype to PI3K downregulation. In addition, if 
one of these genes is involved in the sensing of the recruitment signal of the hemocytes to 
the gut (which is, as we have previously seen, independent of the PI3K signalling), we would 
expect to observe less PV-hemocytes in this genetic context.  
 
Table 2: Results from genetic screen targeting genes involved in hemocyte migration. Resumé of the 
phenotypes obtained when using an RNAi or other type of construct against the indicated genes. Each line was 
analyzed according to: the number of hemocytes present in the proventriculus (PV), in the anterior and posterior 
sessile patches (SP), Lymph Gland phenotype and other observed abnormalities. The number (n) of PV and SP 
analyzed are displayed for each line. p values are shown when the number of hemocytes is significantly different 
between the line and the control: *, p<0.05; **, p<0.01; ***, p<0.001. Hp: Hemocyte phenotype; - : decrease in 
hemocyte number; +: increase in hemocyte number; ns: non-significant. 
Gene 
Observed phenotype 
PV Anterior SP Posterior SP Other 
Hp n Hp n Hp n   
Gα 47A ns 
 
n=19 ns 
 
n=5 ns 
 
n=5 
 
Gα 60A ns 
 
n=11 + 
p=0,0054 
(**) 
n=5 ns 
 
n=5 
 
Gα 49B ns 
 
n=12 + 
p=0,0044 
(**) 
n=5 ns 
 
n=5 
 
Gα 73B - 
p=0,0068 
(**) 
n=13 ns 
 
n=5 - 
p=0,0173 
(*) 
n=5 
 
Gβ 76C ns 
 
n=22 ns 
 
n=5 ns 
 
n=5 
 
Gβ 13F ns 
 
n=7 + 
p=0,0022 
(**) 
n=5 ns 
 
n=4 
 
Mthl5 ns 
 
n=12 ns 
 
n=5 ns 
 
n=5 
 
Mthl6 ns 
 
n=11 ns 
 
n=5 ns 
 
n=5 
 
Mthl8 ns 
 
n=10 ns 
 
n=4 ns 
 
n=4 
 
CG7497 ns 
 
n=10 ns 
 
n=5 ns 
 
n=5 
 
CG4313 ns 
 
n=11 ns 
 
n=5 ns 
 
n=5 
 
GRHR ns 
 
n=10 ns 
 
n=5 ns 
 
n=5 
Abnormal 
Lymph Gland 
GRHRII + 
p=0,0056 
(**) 
n=32 - 
p=0,0266 
(*) 
n=12 ns 
 
n=12 
 
Tre1 - 
p=0,0055 
(**) 
n=15 ns 
 
n=5 ns 
 
n=5 
 
Tre1 
∆EP5
 ns 
 
n=12 ns 
 
n=5 ns 
 
n=5 
 
Moody ns 
 
n=13 ns 
 
n=5 ns 
 
n=5 
 
PVR - 
p=0,0002 
(***) 
n=25 - 
p=0,0157 
(*) 
n=10 - 
p=0,0107 
(*) 
n=10 
Lamellocytes; 
increase in 
Hml negative 
population 
EgfR ns 
 
n=12 ns 
 
n=6 ns 
 
n=6 
 
Btl ns 
 
n=10 + 
p=0,0026 
(**) 
n=5 ns 
 
n=5 
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3.2.1 G-proteins 
In Drosophila there are six α, three β and two γ subunits [70]; we tested the available 
RNAi for four α, and two β subunits (Table 2). Phenotypic classes observed are discussed 
below. 
Absence of significant phenotype: Hemocyte-specific expression of RNAi against Gα 
47A and Gβ 76C subunits gave no significant difference in hemocyte number compared to 
control at either location (Table 2).  
 
Increased number of hemocytes in the anterior SP: Hemocytes expressing RNAi 
against the subunits Gα 60A, Gα 49B and Gβ 13F, gave a mild phenotype: in all three cases, 
there was a significant higher number of hemocytes in the anterior sessile patch, but no 
change for the posterior sessile patch or the PV as compared to the control (Table 2). This 
could suggest a GPCR is required to limit the number of cells at the patch, for example. 
 
Reduced number of hemocytes in the PV and in one SP: The strongest phenotype 
was obtained with Gα 73B RNAi, which lead to a decreased number of hemocytes in the PV 
and in the posterior sessile patch in comparison to the control (Table 2). One possibility is 
that a GPCR is required for the recruitment of hemocytes to these locations. 
 
These changes in hemocyte number could implicate a role for G-proteins (and 
therefore GPCRs) in hemocyte location. Functional redundancy of G protein subunits, in 
particular for the α-subunits, and/or the hypomorphic effect of the RNAi could explain why we 
do not observe stronger phenotypes. 
3.2.2 GPCRs 
The fruitfly genome contains approximately 270 genes coding for GPCRs (Table 2) 
[26], which is a high number of genes to screen. For this reason, we decided to restrict our 
screen to GPCRs known to be expressed in hemocytes. After a thorough bibliographical 
search, largely of microarrays and expression databases, we selected 9 GPCRs that were 
found to be expressed in hemocytes, either at embryonic or larval stages [68, 71, 90].(Table 
2): Mthl5, Mthl6 and Mthl8 from the Methuselah-like Receptor family, some members of 
which have been involved in life span and stress response [70, 91]; GRHR and GRHRII (also 
known as Corazonin Receptor), from the family of the Gonadotropin-releasing hormone 
receptors, of which, GRHR, is known to be required for regulation of fat and carbohydrate 
accumulation and mobilization [92-94]; Trapped in endoderm 1 (Tre1), involved in germ-cell 
migration [71, 72]; Moody, which has a role in maintaining the integrity of the blood-brain 
barrier in the adult fly and regulates drug related behaviours [95]; and lastly 2 GPCRs with 
unknown function: CG7497 and CG4313. Phenotypic classes observed are discussed below. 
 
Absence of significant phenotype: Mthl5, mthl6, mthl8, CG7497, CG4313 and moody 
RNAi-expressing lines did not show significantly different numbers compared to the control, 
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suggesting that these genes are not involved in the recruitment or maintenance of the PV 
and SP hemocytes (Table 2).  
 
Abnormal Lymph gland: When expressing GRHR RNAi in hemocytes, we observed 
an abnormal size and position of the lymph gland (the larval hematopoietic organ) as 
compared to the control (data not shown). Although out of the scope of the screen, this is an 
interesting phenotype, which suggests a role for this receptor in the regulation of hemocyte 
proliferation and differentiation in this organ. 
 
Reduced number of PV-hemocytes but normal number of hemocytes in the SP: Tre1 
RNAi phenotype belongs to this class that suggests a role in hemocyte navigation to the gut, 
but not to the epidermis (Table 2). We attempted to confirm the Tre1 phenotype using a 
mutant allele of the gene, Tre1∆EP5. However, we did not observe a significant difference in 
hemocyte number at the gut or SP in this mutant as compared to the control (Table 2), 
suggesting that our result with Tre1 RNAi is a “false positive” phenotype.  
 
Reduced number of PV-hemocytes and higher number of SP hemocytes: 
Interestingly, this class is comprised of a GPCR of the same family as GRHR, GRHR II (or 
Corazonin Receptor). We observed a phenotype in Hml∆>GFP, GRHR II RNAi progeny that 
resembles the PI3K DN phenotype: more hemocytes in the PV (Fig. 7A-C) and less in the 
anterior SP (Fig. 7D-F). GRHRII could represent an important gene for our studies: a 
receptor acting upstream of PI3K in the regulation of hemocyte localization. In order to 
confirm this particularly interesting candidate, we repeated the experiment, yielding the same 
result (note the large number of animals tested for this gene, Table 2). We will develop in the 
discussion how we are now aiming to further characterize this promising hit. 
 
 
 
Figure 7: GRHRII RNAi presents a similar phenotype to PI3K DN. Representative images of PV from: 
control Hml∆>GFP larva (A) and Hml∆>GFP, GRHR II RNAi larva (B). C: Statistical analysis of PV-hemocyte 
number revealing a higher number in Hml∆>GFP, GRHR II RNAi larvae as compared to control. D, E: 
Representative image of the dorsal middle region of a prepupa, showing the two middle SP (empty arrow 
heads) from control Hml∆>GFP prepupa (D) and Hml∆>GFP, GRHR II RNAi prepupa (E). F: Statistical analysis 
which reveals a lower number of hemocytes in the anterior SP in Hml∆>GFP, GRHR II RNAi prepupae, when 
compared to control. Anterior is up in all images. *: p<0.05; **: p<0.01. Scale bars: 50 µm for PV and 500 µm for 
prepupa images. 
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3.2.3 RTKs  
We analyzed the following set of RTKs, already described in the Introduction chapter, 
that are known to be expressed in hemocytes (Table 2) [68, 90]: Pvr; Egfr; and btl. 
Phenotypic classes observed are discussed below. 
 
Absence of significant phenotype: We did not observe significant changes in 
hemocyte number at the PV or SP after expression of Egfr RNAi (Table 2). This suggests 
that this RTK is not involved in the regulation of the hemocyte location at these two sites.  
 
Increased number of hemocytes in a sessile patch: We observed that hemocytes 
expressing the btl RNAi accumulated in higher numbers at the level of the anterior SP, as 
compared to the control, while their number at the PV was not modified (Table 2). This could 
imply that Btl signalling is required to limit the number of cells in the patch or direct 
hemocytes to other sites in the larva, for example.  
 
Reduced number of hemocytes in both locations: When we analyzed the Hml∆>GFP, 
Pvr RNAi larvae, we observed a reduced number of hemocytes in the PV (Fig. 8A-C) but 
also in the two SP (Fig. 8D-F). This could reflect a general defect in cell migration of the 
hemocytes to these two different sites, reminiscent of the role of Pvr in hemocyte migration 
and dispersal in embryos [57]. However, it is also known that Pvr is implicated in hemocyte 
survival in embryos [79] therefore a general decrease in hemocyte survival in Hml∆>GFP, 
Pvr RNAi larvae could also be the cause of the decrease in hemocytes in both locations. 
Last, Pvr could be required for both cell survival and migration at larval stages. 
 
 
 
Figure 8: Pvr could play a role in hemocyte migration and/or survival in third instar larvae. A,B: 
Representative images of PV from: control Hml∆>GFP (A) and Hml∆>GFP, PVR RNAi larvae (B). C: Graph 
showing a statistical analysis of PV-hemocyte number reveals a significantly lower number in Hml∆>GFP, PVR 
RNAi larvae, compared to control. D,E: Representative images of dorsal middle region of control Hml∆>GFP (D) 
and Hml∆>GFP, Pvr RNAi prepupae (E) showing two middle SP(empty arrow heads). F: Statistical analysis of 
posterior SP revealing a significantly lower number of hemocytes in Hml∆>GFP, PVR RNAi prepupae, compared 
to control. Anterior is up. *: p<0.05; ***: p<0.001. Scale bars: 50 µm for PV and 500 µm for prepupa images. 
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  When we analyzed Hml∆>GFP, Pvr RNAi ex vivo preparations of circulating 
hemocytes (Fig. 9D-F), we observed that, contrary to control bleeds (Fig. 9A-C), there was a 
high proportion of GFP-negative hemocytes. One hypothesis is that a “positive selection” 
occurs in hemocytes that do not express Hml (GFP-negative hemocytes, usually 5% of the 
total population) and therefore do not express the RNAi either. Indeed, we noticed that GFP-
positive cells were often apoptotic (Fig. 9D, F). In addition, we noticed the presence of 
lamellocytes, which can appear in response to massive cell death in the hemocyte population 
(Fig. 9E). We will debate this issue in more depth in the Discussion section, as well as how to 
uncouple possible effects of Pvr on hemocyte survival and migration. 
 
 
 
 
 
In summary, these results suggest that the screen was sensitive enough to uncover 
several players of the regulation of hemocyte localization. We identified a gene, GRHR that 
could be involved in hemocyte homeostasis and another gene, btl, that could be involved in 
the regulation of hemocyte numbers at the SP. The screen also indicates that the, RTK 
receptor, Pvr, could have a role in hemocyte survival and, possibly also in the recruitment of 
hemocytes to the PV and to the SP. Importantly we identified a GPCR, GRHRII, that could 
Figure 9: Pvr-RNAI expressing hemocyte population differs in gene expression and contains 
lamellocytes. A-C: Representative images of control Hml∆>GFP larval bleeds. D-F: Representative images of 
Hml∆>GFP, Pvr RNAi larval bleeds that show an increase in the GFP-negative population. We also noticed the 
presence of a higher number of GFP-positive cells dying in Hml∆>GFP, Pvr RNAi larvae (empty arrow heads and 
magnified panel in D) and of lamellocytes (E, flat arrow head). Filled arrow heads show examples of GFP-
negative cells in control or Pvr RNAi bleeds. Green: Hml∆>GFP; Red: phalloidin; Blue: DAPI. Scale bars: 20 µm 
for bleeds and 5 µm for magnified panels. 
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be functioning upstream of PI3K in hemocyte localization and could represent the receptor 
we were initially aiming to identify.  
3.3 Downstream of PI3K: what potential downstream effectors can modify hemocyte 
location in the larva? 
PI3K is known to have a wide range of downstream effectors that could potentially 
modify hemocyte behaviour, including migration and adhesion [40]. Our next aim was to 
address which downstream effectors of PI3K regulate hemocyte location in the larva.  
In our characterization of the PI3K phenotype, we noticed a change in the cell 
adhesive properties (3.1.3). Obvious candidates to mediate cell-cell adhesion are the 
Cadherin family of transmembrane binding proteins, which play a key role in the dynamics of 
cell–cell contact formation, cell signalling and remodelling of junctions and tissues [96]. There 
are approximately 16 different Cadherins in the Drosophila genome [97]. In order to know 
whether any of these Cadherins play a role in hemocyte adhesion as a possible effector of 
PI3K we took advantage of the fact that Cadherin-mediated adhesion is strictly Ca2+ 
dependent. We blocked the availability of extracellular Ca2+ by using a Ca2+ chelator, 
ethylene glycol tetraacetic acid (EGTA), and tested whether this treatment had an effect on 
cell clustering in ex vivo preparations of hemocytes, especially in PI3K over-activated (CA) 
context, in which hemocytes tend to aggregate more. We found that hemocyte group sizes 
were reduced in Hml>PI3K CA, control and even Hml>PI3K DN bleeds after treatment 
with the Ca2+ chelator, with single cells becoming more numerous in all contexts (Fig. 10). 
This suggests that the clustering phenotype observed upon PI3K modulation relies on a 
change in Cadherin-mediated hemocyte-hemocyte adhesion.  
 
 
 
We next aimed to determine whether hemocytes express Cadherins. Although 
prohemocytes in the medullary zone of the lymph gland have been reported to express 
Cadherins [98], it has not yet been shown that mature hemocytes can express Cadherins. 
Figure 10: Regulation of hemocyte adhesive properties appears to be Ca 
2+
 dependent. Cell clustering is 
reduced in EGTA-treated hemocyte bleeds. 
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Using immunofluorescence, we tested whether the hemocytes express a well-studied 
Drosophila cadherin, the Drosophila E-cadherin (DEcadh, also known as Shotgun) [99]. We 
detected a low (as compared to the epithelial expression) but distinct expression of DECadh 
in PV-hemocytes, often enriched at cell boundaries (Fig. 11) but we failed to detect any 
expression of this particular Cadherin in circulating hemocytes. 
 
 
 
 
Taken together, this data opens the possibility that Cadherins play a role downstream 
of PI3K signalling in the regulation of hemocyte-hemocyte and hemocyte-epithelium 
adhesion, particularly in the PV. The changes in cell adhesion properties could in turn be, at 
least partially, responsible for the change in hemocyte number observed after modulation of 
PI3K signalling in these two locations. 
  
Figure 11: Hemocyte adhesion in the PV may require Cadherins. DE-Cadh is expressed in PV hemocytes. A: 
Scheme of upper midgut showing the region of the PV imaged in the next panels; PV-enclosed hemocytes are 
illustrated in green. B: anti-DE-Cadh staining highlights PV epithelium (green, first panel). C: anti-GFP 
expression in PV-hemocytes (hml>GFP larva, pseudocoloured red). C: merge, including DAPI staining (blue). 
Arrow heads show DE-Cadh expression in hemocytes which is stronger at cell boundaries. Scale bar represents 
20 µm. 
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Chapter 4. Discussion 
 
To date, most of our knowledge about directed cell migration comes from cell culture 
studies using mammalian cells. It is a major challenge to study single cell migration in the 
complexity of a living organism and observe the behaviour of cells in contact with a variety of 
different stimuli. Therefore, a simple but reliable in vivo system is needed to uncover the 
mechanisms underlying single cell migration and chemotaxis. Drosophila hemocytes have 
recently emerged as a model for cell migration. Indeed, it was shown that they share many 
similarities concerning the basic mechanisms of cell migration with mammalian leukocytes. 
Additionally, the available techniques and genetics of the fruitfly present many advantages 
for identifying genes involved in cell migration in vivo. In this project, we aimed to better 
establish this model system, by uncovering the molecular mechanisms that allow the 
recruitment and maintenance of tissue-associated hemocyte populations at the gut and 
dorsal epithelium of the larva.  
 
4.1 PI3K phenotype characterization 
Here we showed that PI3K regulates the number of PV-enclosed hemocytes at the gut 
(PV) and dorsal epithelium (SP) in L3W larvae. Modulation of PI3K signalling using three 
different constructs was sufficient to alter the size of these populations. Expressing a PI3K 
DN construct specifically in hemocytes, we observed more hemocytes at the PV and less at 
the SP. Conversely, upon expressing PI3K CA constructs we observed less hemocytes at 
the PV and more at the SP (Fig. 4). We show that these differences in number are 
independent of alterations in cell proliferation and survival of hemocytes (Table 1). 
Importantly, PI3K could regulate these two populations in different ways. PI3K is not required 
for recruitment of hemocytes to the PV, as they are present in high numbers when PI3K 
signalling is blocked (PI3K DN). This initial recruitment may involve other signals, possibly 
relying on a GPCR or an RTK. However, our results indicate that PI3K is involved in 
hemocyte maintenance at the PV. Our working model is that hemocytes at the PV are still 
able to sense and respond to signals from the rest of the organism, and that this 
responsiveness is PI3K-dependent. When PI3K is over-activated in the hemocytes they tend 
to leave the PV because of over-responsiveness to attractive signals from other tissues, for 
example the dorsal epithelium. Indeed, our data indicate that PI3K signalling functions in 
hemocyte recruitment and/or adhesion to the dorsal epithelium, since PI3K signalling 
inhibition by PI3K DN expression leads to a decrease in hemocytes at this location. 
Interestingly, the results we obtain in the D. melanogaster resemble recent findings in mouse 
models of colitis, in which the authors observed a higher number of macrophages and more 
inflammation in the gut of mice mutant for PI3Kγ or PI3Kδ [43, 44].  
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In addition, PI3K may have a role in regulating hemocyte morphology and adhesion. 
Hemocytes expressing PI3K CA tend to be more spread, both in the PV and in ex vivo 
preparations (Fig. 5), and also tend to form larger clusters in circulation (Fig. 6). It is possible 
that PI3K modifies hemocyte adhesion to other tissues, one possible way of regulating 
tissue-associated hemocyte populations. 
 
 
4.2 Genetic screen to find receptors working upstream of PI3K 
We performed an RNAi-based genetic screen to uncover RTKs and GPCRs and their 
associated G-proteins involved in hemocyte recruitment to the PV and SP. We were 
especially interested in finding a phenotype similar to the PI3K DN phenotype, which could 
indicate an involvement of the target receptor upstream of PI3K in this process. We chose a 
candidate approach, testing in priority genes that were described to be expressed in 
hemocytes. This type of screen has advantages and disadvantages when compared to an 
unbiased screen. It is faster, since the number of candidates found to be specifically 
expressed in hemocytes is much smaller than the total number of GPCRs and RTKs coded 
by the D. melanogaster genome; but consequently, there is also a higher probability of 
missing an important candidate. We used RNAi for the screen, because of its many 
advantages: it enables a fast and efficient silencing of endogenous gene expression in a 
tissue-specific manner (here, in hemocytes), whereby flies are often viable; large libraries of 
RNAi lines are now available, allowing one to target any gene of interest; and newer libraries 
have targeted insertions, thus eliminating one cause of off-target effects. Disadvantages 
include inefficiency in silencing target gene expression (hypomorphism), which can 
potentially give rise to false negatives; and off-target effects, due for example to sequence 
similarities with another gene, which can lead to false positives. It is essential to take into 
account all these issues when analyzing the data and use alternative techniques to 
overcome these problems, for example by using mutants to confirm RNAi phenotypes. 
This genetic screen allowed us to uncover several genes that could be involved in 
regulating hemocyte homeostasis and recruitment. However, we decided to focus the 
discussion on the two most interesting results, obtained with RNAi against GRHRII and Pvr.  
4.2.1 GRHRII 
The first indications that a GPCR could be acting upstream of PI3K were the 
phenotypes observed in larvae with RNAi against different G-protein subunits (Table 2). 
However, these results were difficult to interpret due to potential redundancy between G 
protein subunits, added to a likely incomplete loss-of-function due to RNAi hypomorphism. 
GRHRII RNAi larvae presented a phenotype that we were most interested in further 
analyzing, since it was similar to that obtained in the PI3K DN context: more hemocytes at 
the PV and less in the SP (Fig. 7). This suggests that this GPCR might function upstream of 
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PI3K in regulating the number of hemocytes at these two locations. Importantly, to date no 
GPCR has been found in Drosophila that is required for hemocyte recruitment, which makes 
this finding very interesting. However, GRHRII RNAi possesses a less striking phenotype 
than the one obtained with PI3K DN: only the anterior SP had significantly less hemocytes 
when compared to control (Table 2). This could be explained by the inefficiency of the RNAi 
in completely abolishing expression of the receptor; a low level of remaining expression 
could be enough to trigger a signal that could then be amplified inside the cell, leading to a 
subtler phenotype. Another possible explanation is redundancy between receptors of the 
same family, such as between GRHRII and GRHR. This hypothesis seems unlikely in this 
case, as GRHR and GRHRII RNAi gave different phenotypes in our screen.  
To further confirm the GRHRII phenotype and make sure that this result is not a false 
positive, due to an off-target effect for example, we will now test a mutant line for GRHRII. 
The importance of this confirmation is reinforced by the example of the Tre1 RNAi 
phenotype, which we identified as a false positive result when it was not confirmed by the 
Tre1 mutant. Another way of testing whether this receptor is important for hemocyte 
recruitment will be to misexpress its ligand, corazonin (Crz), in a specific location, and see 
whether this is sufficient to recruit hemocytes. Lastly, one of the main questions remaining to 
be addressed is whether this receptor is indeed working upstream of PI3K, which will be 
tested by epistatic analysis of GRHRII and PI3K. 
 
4.2.2 Pvr 
Pvr was previously described to be required for hemocyte migration and survival in 
the embryo [57, 79]. During our analysis of Pvr RNAi, we observed fewer hemocytes in both 
the PV and SP (Fig.8). These effects could be explained by either a general defect in cell 
survival (hemocytes start to die when Pvr expression is down-regulated), or an impairment in 
cell migration (hemocytes require Pvr to migrate to these locations), or both. When we 
analyzed bleeds of HmlΔ>Pvr RNAi larvae, we found that most circulating hemocytes were 
GFP-negative (Fig.9), meaning that they were not expressing the HmlΔ-Gal4 driver, which is 
normally expressed in 95% of all hemocytes in the L3W larvae. Consequently, it is possible 
that in our experiments on Pvr we were unable to visualize and therefore quantify a 
proportion of the hemocytes, making the results difficult to interpret. This problem highlights 
one disadvantage of using the GAL4/UAS system; the labelling of cells is not direct, which 
means that if expression of the driver gene is down-regulated, the cells will lose GFP 
expression and will no longer be visualized.  
Several explanations could account for the decrease in the GFP-positive hemocyte 
population. It could be due to a down-regulation of Hml expression in the Pvr RNAi context, 
which would imply that Pvr is required for Hml expression, as yet unreported. Another 
possibility is that the two UAS constructs present in the HmlΔ -GAL4, UAS-GFP; UAS-Pvr 
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RNAi larvae are competing for the GAL4 transcription factor, decreasing the amount of GAL4 
protein available to activate both UAS promoters. However, this situation is not observed for 
other RNAi constructs, which makes this hypothesis less likely. Finally, the observed effect 
could be the result of a positive selection: as Pvr is important for hemocyte survival, cells 
expressing HmlΔ-Gal4 and thus UAS-Pvr RNAi (and UAS-GFP) would be disadvantaged in 
comparison to cells not expressing HmlΔ-Gal4. As a consequence, HmlΔ-Gal4>Pvr RNAi, 
GFP cells would tend to undergo apoptosis while the 5% of cells not expressing HmlΔ-Gal4 
would continue proliferating, eventually representing a much larger proportion of the 
population than normal. One way to corroborate this hypothesis is to perform TUNEL 
analysis and PH3 immunostaining to see whether GFP-positive hemocytes have a higher 
rate of apoptosis and/or GFP-negative hemocytes a higher rate of proliferation.  
In order to determine whether Pvr is involved in hemocyte recruitment to the PV or 
solely modifies global survival, we will need to uncouple the potential survival and migration 
effects of Pvr in the L3W larvae. In order to do so, we can attempt to modulate the 
expression of the ligands, instead of the receptor itself. Misexpression or down-regulation (by 
RNAi) of Pvr ligands Pvf-1,-2 and -3, in the PV should indicate whether Pvf/Pvr signalling is 
needed for hemocyte recruitment to this location. Interestingly, at late embryogenesis the PV 
starts to express Pvf-1 and 2, which further suggests that Pvr is required for hemocyte 
recruitment to the PV in response to this signal (Berkeley Drosophila Genome Project). 
 
4.3  Possible downstream effectors of PI3K  
We observed, upon modulation of PI3K signalling, changes in cell shape and in the 
rate of adhesion between hemocytes in circulation in the PI3K CA context. Obvious 
candidates that could function downstream of PI3K and mediate cell-cell adhesion are 
Cadherins. This hypothesis was reinforced by the decrease in hemocyte clustering after 
EGTA treatment (Fig. 10). We also observed that PV-enclosed hemocytes expressed DE-
cadherin, suggesting a role for DE-cadherin in adhesion of hemocytes to the PV epithelium 
(Fig. 11). However, we were not able to observe the expression of this Cadherin in circulating 
hemocytes, which could indicate that other types of Cadherin are involved in hemocyte-
hemocyte interactions. To determinate which Cadherin is responsible for adhesion between 
hemocytes, we could perform a new screen in which we silence the expression of each 
Cadherin, either alone or in a PI3K CA context, to see which one abolishes the clustering 
phenotype (“modifier” screen). To limit the number of Cadherins to test (there are 
approximately 16 Cadherin genes in the fly genome), we could first perform expression 
analysis in hemocytes using available antibodies against other Cadherins. Together, our 
results suggest that Cadherins could act as downstream effectors of PI3K signalling in the 
regulation of hemocyte-hemocyte and hemocyte-gut epithelium adhesion. This change of 
adhesion could in turn account, at least in part, for the PI3K-dependent regulation of 
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hemocyte localisation. It must be noted that other types of adhesion molecules, such as 
integrins, could also be involved in hemocyte adhesion. More generally, it is likely that PI3K 
regulates different aspects of hemocyte biology through diverse effectors that together 
contribute to the hemocyte localization phenotypes we observe. 
 
4.4 Final remarks 
Populations of cells associated with tissues are maintained through a succession of 
key events, including i) cell migration towards the tissue in response to a signalling cue, and 
ii) retention, possibly through adhesion, of the cells in that particular location. Here we 
analyzed potential molecules and receptors that could be important for recruitment and 
maintenance of two tissue-associated hemocyte populations in D. melanogaster larvae. 
We demonstrate that PI3K is involved in the regulation of hemocyte localization, 
possibly, in part, through Cadherin-mediated modulation of hemocyte adhesive properties. 
Importantly, we also provide insights into potential receptors involved in hemocyte 
recruitment and population maintenance in the PV and in the SP. Although much work 
remains to establish their functions, we can propose a preliminary working model, in which 
the RTK Pvr, independently of PI3K, recruits hemocytes to the PV, where its ligands Pvf-1 
and -2 appear to be expressed. Concurrently, hemocytes receive recruitment signals from 
other locations in the organism, such as the dorsal epithelium. These signals are received 
through the GPCR GRHRII, which in turn activates PI3K. 
If we can confirm the involvement of this GPCR in the regulation of hemocyte 
navigation it will be very interesting in terms of evolution. While mammalian leukocytes 
undergo chemotaxis mainly through chemokine receptors, the Drosophila genome does not 
code for GPCRs from the chemokine receptor subfamily and remarkably, no other GPCRs 
have yet been implicated in hemocyte navigation. Therefore GRHRII could be the first GPCR 
regulating immune cell migration in the fruitfly. One interesting question for the future is 
whether this GPCR or others are involved in the recruitment of hemocytes in „crisis‟ 
situations, such as the response to damaged or infected tissues. 
Taken together, our results indicate that hemocyte navigation in the D. melanogaster 
larva is tightly regulated, and strongly suggest that hemocytes have to integrate competing 
signals from different tissues in their passage through the organism. Importantly, our data 
provide new insights about the signalling pathways that regulate hemocyte migration in the 
larva, and recruitment and maintenance at target tissues. We hope this work will contribute to 
better establish Drosophila hemocytes as a model for single cell migration in vivo. 
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Gene Construct/Genotype Type 
Affected 
Cromosome 
Controls used 
PI3K  P{UAS-Pi3K92E.CAAX}1, y1, w1118                                   (BL8294) UAS-CA X y1, w1118 
 
P{Dp110-CAAX}1, y
1
, w*                                      (BL25908) UAS-Camyc X y
1
, w
1118
 
 
y
1
,
 
w*; P{Dp110D954A}2                                      (BL25918) UAS-DN III y
1
, w
1118
 
Rac1 y1, w*; P{UAS-Rac1.V12}1                                   (BL6291) UAS-CA III y1, w1118 
 
y
1
, w*; P{UAS-Rac1.N17}1                                   (BL6292) UAS-DN III y
1
, w
1118
 
Gα 47A y, w1118;P{KK110552} UAS-RNAi II y,w1118;P{attP,y[+],w[3`]} 
Gα 60A y, w1118;P{KK105485} UAS-RNAi II y,w1118;P{attP,y[+],w[3`]} 
Gα 49B y, w1118;P{KK105300} UAS-RNAi II y,w1118;P{attP,y[+],w[3`]} 
Gα 73B y1, v1; P{y[+t7.7] v[+t1.8]=TRiP.JF01950}attP2    (BL25930) UAS-RNAi III y1, v1 
Gβ 76C y, w1118;P{KK104745} UAS-RNAi II y,w1118;P{attP,y[+],w[3`]} 
Gβ 13F y, w1118;P{KK100011} UAS-RNAi II y,w1118;P{attP,y[+],w[3`]} 
Mthl 5 y, w1118;P{KK101593} UAS-RNAi II y,w1118;P{attP,y[+],w[3`]} 
Mthl 6 y, w1118;P{KK108048} UAS-RNAi II y,w1118;P{attP,y[+],w[3`]} 
Mthl 8 y, w1118;P{KK100246} UAS-RNAi II y,w1118;P{attP,y[+],w[3`]} 
CG7497 y, w1118;P{KK106421} UAS-RNAi II y,w1118;P{attP,y[+],w[3`]} 
CG4313 y, w1118;P{KK107434} UAS-RNAi II y,w1118;P{attP,y[+],w[3`]} 
GRHR y, w1118;P{KK109300 } UAS-RNAi II y,w1118;P{attP,y[+],w[3`]} 
GRHR II y1, v1; P{y[+t7.7] v[+t1.8]=TRiP.JF02042}attP2    (BL26017) UAS-RNAi III y1, v1 
Tre1 y, w1118;P{KK108952 } UAS-RNAi II y,w1118;P{attP,y[+],w[3`]} 
Tre1
∆EP5
 w1118, Tre1∆EP5 Mutant  X w1118 
Moody y, w1118;P{KK109601} UAS-RNAi II y,w1118;P{attP,y[+],w[3`]} 
PVR y, w1118;P{KK105353} UAS-RNAi II y,w1118;P{attP,y[+],w[3`]} 
EgfR y, w1118;P{KK107130} UAS-RNAi II y,w1118;P{attP,y[+],w[3`]} 
Btl  y, w1118;P{KK110277} UAS-RNAi II y,w1118;P{attP,y[+],w[3`]} 
 
w
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 Control   
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1
, w
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 Control BL lines 
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Control VDRC 
lines II 
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Supplementary Figure 1: Phosphohistone H3 (PH3) immunostaining of PV and Bleeds. Representative 
images of bleeds (A-C) and PV-hemocytes (D-F) subjected to immunostaining for PH3. A, D: Control 
(Hml∆>GFP). B, E: Hml∆>GFP, PI3K DN (DN).C, F: Hml∆>GFP, PI3K CAmyc (CA). Green: anti-GFP; blue: DAPI, 
red: anti-PH3. An example of a positive cell in a control bleed (arrow head) is shown in A (magnified view). No 
hemocytes were found positive for PH3 in the PV but the presence of PH3-positive cells in a known stem cell 
region (represented by the dashed orange line) of the PV  could be detected (arrow heads). Bar scales represent 
20 µm and 5 µm (magnified panel). 
 
